Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tingting Feng

Showing results (351-360 of 358) with videos related to

Pageof 36
Sort By:
You have reached the last page of results.This site can display upto 358 results.
Journal for Immunotherapy of Cancer|November 29, 2023
TP53/mTORC1-mediated bidirectional regulation of PD-L1 modulates immune evasion in hepatocellular carcinomaJiongjie Yu, Sunbin Ling, Jiachen Hong, et al.
Signal Transduction and Targeted Therapy|September 19, 2024
The p-MYH9/USP22/HIF-1α axis promotes lenvatinib resistance and cancer stemness in hepatocellular carcinomaQiaonan Shan, Lu Yin, Qifan Zhan, et al.
Gut|November 29, 2019
USP22 promotes hypoxia-induced hepatocellular carcinoma stemness by a HIF1α/USP22 positive feedback loop upon TP53 inactivationSunbin Ling, Qiaonan Shan, Qifan Zhan, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 9, 2024
Lactylated Apolipoprotein C-II Induces Immunotherapy Resistance by Promoting Extracellular LipolysisJian Chen, Deping Zhao, Yupeng Wang, et al.
Protein & Cell|March 4, 2024
Microbiota enterotoxigenic Bacteroides fragilis-secreted BFT-1 promotes breast cancer cell stemness and chemoresistance through its functional receptor NOD1Wei Ma, Lu Zhang, Weilong Chen, et al.
Journal of Hepatology|June 6, 2021
Development and validation of a new prognostic score for hepatitis B virus-related acute-on-chronic liver failureJiaqi Li, Xi Liang, Shaoli You, et al.
Gut|September 21, 2017
Development of diagnostic criteria and a prognostic score for hepatitis B virus-related acute-on-chronic liver failureTianzhou Wu, Jiang Li, Li Shao, et al.
Gut|July 25, 2025
Performance of the China-CLIF framework in acute-on-chronic liver failure: a multicohort study across all aetiologiesJinjin Luo, Meiqian Hu, Tingting Feng, et al.
Pageof 36

Showing results (351-360 of 358) with videos related to

Sort By:
Pageof 36
You have reached the last page of results.This site can display upto 358 results.
Journal for Immunotherapy of Cancer|November 29, 2023
TP53/mTORC1-mediated bidirectional regulation of PD-L1 modulates immune evasion in hepatocellular carcinomaJiongjie Yu, Sunbin Ling, Jiachen Hong, et al.
Signal Transduction and Targeted Therapy|September 19, 2024
The p-MYH9/USP22/HIF-1α axis promotes lenvatinib resistance and cancer stemness in hepatocellular carcinomaQiaonan Shan, Lu Yin, Qifan Zhan, et al.
Gut|November 29, 2019
USP22 promotes hypoxia-induced hepatocellular carcinoma stemness by a HIF1α/USP22 positive feedback loop upon TP53 inactivationSunbin Ling, Qiaonan Shan, Qifan Zhan, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 9, 2024
Lactylated Apolipoprotein C-II Induces Immunotherapy Resistance by Promoting Extracellular LipolysisJian Chen, Deping Zhao, Yupeng Wang, et al.
Protein & Cell|March 4, 2024
Microbiota enterotoxigenic Bacteroides fragilis-secreted BFT-1 promotes breast cancer cell stemness and chemoresistance through its functional receptor NOD1Wei Ma, Lu Zhang, Weilong Chen, et al.
Journal of Hepatology|June 6, 2021
Development and validation of a new prognostic score for hepatitis B virus-related acute-on-chronic liver failureJiaqi Li, Xi Liang, Shaoli You, et al.
Gut|September 21, 2017
Development of diagnostic criteria and a prognostic score for hepatitis B virus-related acute-on-chronic liver failureTianzhou Wu, Jiang Li, Li Shao, et al.
Gut|July 25, 2025
Performance of the China-CLIF framework in acute-on-chronic liver failure: a multicohort study across all aetiologiesJinjin Luo, Meiqian Hu, Tingting Feng, et al.
Pageof 36